Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Invest NowTata India Pharma & Healthcare Fund-Regular Plan-Growth
Invest NowChart Comparison
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3416 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 1.95 | 2.14 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -2.13% | -3.04% |
6 Month | 14.55% | 9.88% |
1 Year | 30.1% | 27.65% |
3 Year | 23.13% | 20.65% |
5 Year | 27.58% | 25.56% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 23.89% | 19.99% |
3 Year | 31.58% | 29.34% |
5 Year | 25.73% | 23.84% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 14.51% | 6.67% |
3 Year | 17.07% | 17.46% |
5 Year | 12.42% | 14.22% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.02% | 14.23% |
Sharp | 1.04% | 0.74% |
Beta | 0.8% | 0.9% |
Alpha | 5.51% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Fund Manage | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 7.82 | 5.39 |
Small Cap | 37.28 | 23.46 |
Mid Cap | 24.84 | 30.82 |
Large Cap | 30.06 | 40.33 |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 7.82 | 5.39 |
Pharmaceuticals & Biotechnology | 57.84 | 76.28 |
Healthcare Services | 25.46 | 14.31 |
Chemicals & Petrochemicals | 3.5 | 0.39 |
Healthcare Equipment & Supplies | 5.38 | - |
Fertilizers & Agrochemicals | - | 0.83 |
Insurance | - | 2.14 |
Retailing | - | 0.66 |
Top Comparisons
Nippon India Corporate Bond Fund - Growth Plan - Growth Option
3Y Returns6.68%
PGIM India Corporate Bond Fund - Growth
3Y Returns5.77%
Franklin India Flexi Cap Fund - Growth
3Y Returns15.9%
HSBC Flexi Cap Fund - Regular Growth
3Y Returns14.17%
Canara Robeco Blue Chip Equity Fund - Regular Plan - Growth Option
3Y Returns11.29%
LIC MF Large Cap Fund-Growth
3Y Returns8.3%
SBI Retirement Benefit Fund - Aggressive Plan - Regular Plan - Growth
3Y Returns12.52%
Nippon India Retirement Fund- Wealth Creation Scheme- Growth Plan - Growth Option
3Y Returns14.65%